NM_005120.3:c.6351G>T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005120.3(MED12):​c.6351G>T​(p.Gln2117His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000019 in 1,053,642 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. Q2117Q) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000019 ( 0 hom. 0 hem. )

Consequence

MED12
NM_005120.3 missense

Scores

1
2
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.176

Publications

0 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10450241).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.6351G>T p.Gln2117His missense_variant Exon 43 of 45 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.6351G>T p.Gln2117His missense_variant Exon 43 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
0.00000190
AC:
2
AN:
1053642
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
344456
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24903
American (AMR)
AF:
0.00
AC:
0
AN:
27913
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18639
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27135
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49842
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37656
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4077
European-Non Finnish (NFE)
AF:
0.00000244
AC:
2
AN:
819109
Other (OTH)
AF:
0.00
AC:
0
AN:
44368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.062
T;.;T
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.52
T;T;T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.10
T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.81
.;.;L
PhyloP100
0.18
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.2
.;N;N
REVEL
Benign
0.077
Sift
Pathogenic
0.0
.;D;D
Sift4G
Uncertain
0.032
D;D;D
Polyphen
0.0
B;B;B
Vest4
0.24
MutPred
0.19
.;.;Loss of helix (P = 0.5596);
MVP
0.53
MPC
0.66
ClinPred
0.23
T
GERP RS
1.5
Varity_R
0.24
gMVP
0.44
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1175039083; hg19: chrX-70361163; API